Tempest Therapeutics, Inc. — All Filings
973 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
144
3
4
4/A
424B2
424B3
424B5
425
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFM14A
EFFECT
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001415889-25-000806 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000807 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000805 | Jan 6, 2025 | Jan 2, 2025 |
| 8-K | 8-K | 0001193125-24-287170 | Dec 31, 2024 | Dec 27, 2024 |
| 8-K | 8-K | 0001193125-24-272464 | Dec 6, 2024 | Dec 3, 2024 |
| DEF 14A | DEF 14A | 0001140361-24-046210 | Nov 12, 2024 | Dec 3, 2024 |
| 10-Q | 10-Q | 0000950170-24-125499 | Nov 12, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0000950170-24-125444 | Nov 12, 2024 | — |
| PRE 14A | PRE 14A | 0001140361-24-044533 | Oct 29, 2024 | Dec 3, 2024 |
| 8-K | 8-K | 0001193125-24-235598 | Oct 10, 2024 | Oct 7, 2024 |
| 8-A12B/A | 8-A12B/A | 0001193125-24-235607 | Oct 10, 2024 | — |
| 144 | — | 0000950170-24-095769 | Aug 13, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-24-199144 | Aug 12, 2024 | — |
| 4 | 4 | 0000950170-24-095675 | Aug 12, 2024 | Aug 8, 2024 |
| 144 | — | 0001178937-24-000041 | Aug 9, 2024 | — |
| 8-K | 8-K | 0000950170-24-094102 | Aug 8, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-094124 | Aug 8, 2024 | Jun 30, 2024 |
| UPLOAD | — | 0000000000-24-008307 | Jul 23, 2024 | — |
| S-3 | S-3 | 0001193125-24-181673 | Jul 19, 2024 | — |
| 4 | — | 0001415889-24-019339 | Jul 8, 2024 | Jul 3, 2024 |
| 4 | — | 0001415889-24-019279 | Jul 3, 2024 | Jul 2, 2024 |
| 4 | — | 0001415889-24-018866 | Jul 2, 2024 | Jun 28, 2024 |
| 8-K | 8-K | 0001193125-24-164015 | Jun 20, 2024 | — |
| 424B5 | 424B5 | 0001193125-24-164037 | Jun 20, 2024 | — |
| 4 | — | 0001415889-24-017011 | Jun 14, 2024 | Jun 13, 2024 |
| 4 | — | 0001415889-24-017012 | Jun 14, 2024 | Jun 13, 2024 |
| 8-K | 8-K | 0001193125-24-161685 | Jun 14, 2024 | Jun 13, 2024 |
| 4 | — | 0001415889-24-017009 | Jun 14, 2024 | Jun 13, 2024 |
| 4 | — | 0001415889-24-017010 | Jun 14, 2024 | Jun 13, 2024 |
| SC 13D/A | SC 13D/A | 0001193125-24-137304 | May 13, 2024 | — |
| 8-K | 8-K | 0000950170-24-057047 | May 9, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-057072 | May 9, 2024 | Mar 31, 2024 |
| ARS | ARS | 0001193125-24-106980 | Apr 23, 2024 | Dec 31, 2023 |
| DEF 14A | DEF 14A | 0001193125-24-106959 | Apr 23, 2024 | Jun 13, 2024 |
| DEFA14A | DEFA14A | 0001193125-24-106971 | Apr 23, 2024 | — |
| S-8 | S-8 | 0001193125-24-071472 | Mar 19, 2024 | — |
| 8-K | 8-K | 0000950170-24-033464 | Mar 19, 2024 | — |
| 10-K | 10-K | 0000950170-24-033555 | Mar 19, 2024 | Dec 31, 2023 |
| SC 13G/A | — | 0001172661-24-001212 | Feb 14, 2024 | — |
| SC 13G/A | — | 0000935836-24-000223 | Feb 14, 2024 | — |
| SC 13G/A | — | 0000315066-24-001539 | Feb 9, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-24-028545 | Feb 8, 2024 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-24-001040 | Jan 5, 2024 | Jan 3, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-001035 | Jan 5, 2024 | Jan 3, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-001036 | Jan 5, 2024 | Jan 3, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-001038 | Jan 5, 2024 | Jan 3, 2024 |
| S-8 POS | S-8 POS | 0001193125-23-279846 | Nov 17, 2023 | — |
| S-8 POS | S-8 POS | 0001193125-23-279849 | Nov 17, 2023 | — |
| S-8 POS | S-8 POS | 0001193125-23-279851 | Nov 17, 2023 | — |
| S-8 POS | S-8 POS | 0001193125-23-279857 | Nov 17, 2023 | — |